FMRI-based prediction of naltrexone response in alcohol use disorder: a replication study

Pharmacological treatment in alcohol use disorder suffers from modest effect sizes. Efforts have been undertaken to identify patient characteristics that help to select individuals that benefit from pharmacological treatment. Previous studies indicated that neural alcohol cue-reactivity (CR) might p...

Full description

Saved in:
Bibliographic Details
Main Authors: Bach, Patrick (Author) , Weil, Georg (Author) , Pompili, Enrico (Author) , Hoffmann, Sabine (Author) , Hermann, Derik (Author) , Vollstädt-Klein, Sabine (Author) , Kiefer, Falk (Author) , Mann, Karl (Author) , Sommer, Wolfgang H. (Author)
Format: Article (Journal)
Language:English
Published: 21 April 2021
In: European archives of psychiatry and clinical neuroscience
Year: 2021, Volume: 271, Issue: 5, Pages: 915-927
ISSN:1433-8491
DOI:10.1007/s00406-021-01259-7
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00406-021-01259-7
Get full text
Author Notes:Patrick Bach, Georg Weil, Enrico Pompili, Sabine Hoffmann, Derik Hermann, Sabine Vollstädt-Klein, Falk Kiefer, Karl Mann, Wolfgang H. Sommer
Description
Summary:Pharmacological treatment in alcohol use disorder suffers from modest effect sizes. Efforts have been undertaken to identify patient characteristics that help to select individuals that benefit from pharmacological treatment. Previous studies indicated that neural alcohol cue-reactivity (CR) might provide a marker that identifies patients, which benefit from naltrexone treatment.
Item Description:Published online: 21 April 2021
Gesehen am 05.12.2022
Physical Description:Online Resource
ISSN:1433-8491
DOI:10.1007/s00406-021-01259-7